TREATMENT OF METASTATIC MALIGNANT-MELANOMA WITH RECOMBINANT INTERFERON ALPHA-2

被引:56
作者
ROBINSON, WA
MUGHAL, TI
THOMAS, MR
JOHNSON, M
SPIEGEL, RJ
机构
关键词
D O I
10.1016/S0171-2985(86)80109-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:275 / 282
页数:8
相关论文
共 13 条
[1]  
ABRAMS PG, 1985, NEW ENGL J MED, V312, P443
[2]  
COMIS RL, 1985, CURR CONCEPTS ONCOL, V4, P18
[3]   PHASE-II STUDY OF LOW-DOSE RECOMBINANT LEUKOCYTE-A INTERFERON IN DISSEMINATED MALIGNANT-MELANOMA [J].
CREAGAN, ET ;
AHMANN, DL ;
GREEN, SJ ;
LONG, HJ ;
FRYTAK, S ;
OFALLON, JR ;
ITRI, LM .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (09) :1002-1005
[4]  
HOCHSTER H, 1985, CANCER TREAT REP, V69, P39
[5]   INTERFERONS IN THE TREATMENT OF HUMAN CANCER [J].
KIRKWOOD, JM ;
ERNSTOFF, MS .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (04) :336-352
[6]   COMPARISON OF INTRAMUSCULAR AND INTRAVENOUS RECOMBINANT ALPHA-2 INTERFERON IN MELANOMA AND OTHER CANCERS [J].
KIRKWOOD, JM ;
ERNSTOFF, MS ;
DAVIS, CA ;
REISS, M ;
FERRARESI, R ;
RUDNICK, SA .
ANNALS OF INTERNAL MEDICINE, 1985, 103 (01) :32-36
[7]   THE RISING INCIDENCE AND MORTALITY-RATE OF MALIGNANT-MELANOMA [J].
KOPF, AW ;
RIGEL, DS ;
FRIEDMAN, RJ .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1982, 8 (09) :760-761
[8]  
KROWN SE, 1984, CANCER TREAT REP, V68, P723
[9]  
MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[10]  
2-6